MD1003 in Progressive Multiple Sclerosis: 24-Month Brain Volume Changes of the MS-SPI Trial

被引:0
|
作者
Arnold, Douglas L. [1 ]
Ranjeva, Jean-Phillipe [2 ]
Pelletier, Jean [3 ]
Barillot, Christian [4 ]
Jean, Betty [5 ]
Galanaud, Damien [6 ]
Pierot, Laurent [7 ]
Papeix, Caroline [8 ]
Edan, Gilles [9 ]
Clavelou, Pierre [10 ]
Simon, Olivier [11 ]
Sedel, Frederic [11 ]
Tourbah, Ayman [12 ]
Berry, Isabelle [13 ]
Morteau, Olivier [11 ]
Lasser, Robert [11 ]
机构
[1] McGill Univ, Montreal, PQ, Canada
[2] Aix Marseille Univ, Marseille, France
[3] Hop La Timone, AP HM, Marseille, France
[4] Univ Rennes, Rennes, France
[5] CHU Gabriel Montpied, Clermont Ferrand, France
[6] Univ Paris 06, Paris, France
[7] Ctr Hosp Univ Reims, Reims, France
[8] Hop La Pitie Salpetriere, Paris, France
[9] CH Pontchaillou, Rennes, France
[10] CHU Clermont Ferrand, Clermont Ferrand, France
[11] MedDay Pharmaceut, Paris, France
[12] Hop Maison Blanche, Reims, France
[13] CHU Toulouse, Toulouse, France
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P133
引用
收藏
页码:70 / 71
页数:2
相关论文
共 50 条
  • [1] MD1003 in progressive multiple sclerosis: 24-month brain MRI results of the MS-SPI trial
    Arnold, D.
    Ranjeva, J. -P.
    Pelletier, J.
    Barrilot, C.
    Jean, B.
    Galanaud, D.
    Pierot, L.
    Edan, G.
    Clavelou, P.
    Sedel, F.
    Tourbah, A.
    Berry, I.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 35 - 36
  • [2] MD1003 in Progressive Multiple Sclerosis: 24-Month Brain Volume Changes of the MSSPI Trial
    Arnold, Douglas
    Ranjeva, Jean-Philippe
    Pelletier, Jean
    Barillot, Christian
    Jean, Betty
    Galanaud, Damien
    Pierot, Laurent
    Edan, Gilles
    Clavelou, Pierre
    Sedel, Frederic
    Tourbah, Ayman
    Berry, Isabelle
    [J]. NEUROLOGY, 2018, 90
  • [3] MD1003 (high doses of biotin) in progressive multiple sclerosis: subgroup analyses of the MS-SPI trial
    Tourbah, A.
    Lebrun-Frenay, C.
    Edan, G.
    Clanet, M.
    Papex, C.
    Vukusic, S.
    De Sesze, J.
    Debouverie, M.
    Gout, O.
    Clavelou, P.
    Defer, G.
    Laplaud, D.
    Moreau, T.
    Labauge, P.
    Brochet, B.
    Sedel, F.
    Pelletier, J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 785 - 785
  • [4] Effect of MD1003 (High-Dose Biotin) in spinal progressive multiple sclerosis (MS-SPI): subgroup analyses
    Laplaud, D. -A.
    Gout, O.
    Clavelou, P.
    Pelletier, J.
    Sedel, F.
    Tourbah, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 402 - 403
  • [5] 24-Month-Treatment with-MD1003 (High Doses of Biotin) in Progressive Multiple Sclerosis: Results of the MS-SPI Trial Extension Phase
    Tourbah, Ayman
    Lebrun-Frenay, Christine
    Edan, Gilles
    Clane, Michel
    Papeix, Caroline
    Vukusic, Sandra
    De Seze, Jerome
    Debouverie, Marc
    Gout, Olivier
    Clavelou, Pierre
    Defer, Gilles
    Laplaud, David
    Moreau, Thibault
    Labauge, Pierre
    Brochet, Bruno
    Sedel, Frederic
    Pelletier, Jean
    [J]. NEUROLOGY, 2016, 86
  • [6] Effect of MD1003 (High-Dose Pharmaceutical Biotin) in Spinal Progressive Multiple Sclerosis (MS-SPI): Subgroup Analyses
    Laplaud, David-Axel
    Gout, Olivier
    Clavelou, Pierre
    Pelletier, Jean
    Simon, Olivier
    Sedel, Frederic
    Tourbah, Ayman
    Lasser, Robert
    Morteau, Olivier
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 33 - 33
  • [7] Effect of MD1003 (High-Dose Biotin) in spinal progressive multiple sclerosis (MS-SPI): EDSS sub-scores
    Papeix, C.
    Lebrun-Frenay, C.
    Defer, G.
    Labauge, P.
    Ruiz, M.
    Simon, O.
    Tourbah, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 938 - 939
  • [8] Effect of MD1003 (High-Dose Pharmaceutical Biotin) in Spinal Progressive Multiple Sclerosis (MS-SPI): EDSS Sub-Scores
    Papeix, Caroline
    Lebrun-Frenay, Christine
    Defer, Gilles
    Laubage, Pierre
    Ruiz, Marta
    Simon, Olivier
    Sedel, Frederic
    Tourbah, Ayman
    Lasser, Robert
    Morteau, Olivier
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 34 - 34
  • [9] Comorbidities and safety of use of MD1003 in a cohort of patients with progressive multiple sclerosis
    Donze, C.
    Cattoir, H.
    Hautecoeur, P.
    Kwiatkowski, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 817 - 818
  • [10] High doses of biotin in progressive multiple sclerosis: extension phase results of the MS-SPI trial
    Tourbah, A.
    Lebrun-Frenay, C.
    Edan, G.
    Clanet, M.
    Papeix, A. -C.
    Vukusic, S.
    de Seze, J.
    Debouverie, M.
    Gout, O.
    Clavelou, P.
    Defer, G. L.
    Laplaud, D.
    Moreau, T.
    Labauge, P.
    Brochet, B.
    Sedel, F.
    Pelletier, J.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 70 - 70